COVID-19 vaccine maker Novavax has announced that it will lay off a quarter of its employees as the company faces “substantial challenges” this year amid the easing of the pandemic. Novavax is focusing on “significantly reducing” its expenses while maintaining critical capabilities that are necessary to execute the company’s operating plans, the firm said in…

NEW YORK—COVID-19 vaccine maker Novavax Inc. on Tuesday raised doubts about its ability to remain in business and announced plans to slash spending as it works to prepare for a fall vaccination campaign, and its shares plunged more than 25 percent. The company said there is significant uncertainty around its 2023 revenue, funding from the…

A higher than expected number of heart inflammation cases have occurred in people who received Novavax’s COVID-19 vaccine, researchers reported in a new study. Sixty-one cases of myocarditis, pericarditis, or both following a Novavax vaccination were reported in the World Health Organization’s vaccine safety database through Aug. 23, 2022, Spanish researchers found. Using pre-pandemic rates of…

Novavax has secured a vaccine deal to provide the U.S. government with 1.5 million doses of its COVID-19 vaccine, a latecomer to a market where the biggest buyers have stopped buying. The Maryland-based biotech company reported on Monday that it has agreed with the U.S. government to modify an existing contract, but did not disclose…

Four Australian senators have lodged an order for the release of contracts between the federal government and pharmaceutical companies for the production of COVID-19 vaccines. The senators will lodge the motion on Nov. 29, 2022, for the current Labor health minister to release agreements with Pfizer, AstraZeneca, Moderna, and Novavax, including details on vaccine efficacy,…

An Air Force veteran and attorney is calling into question the Pentagon and Air Force’s promotion of Novavax as a vaccine that doesn’t have links to fetal-derived cell lines, saying that this is not the case. With nearly 20 years of military service, Lt. Col. Davis Younts currently serves as an Air Force Reserve Judge…

The Centers for Disease Control and Prevention (CDC) on Monday signed off on the use of Novavax Inc.’s COVID-19 vaccine for adolescents aged 12 through 17. The recommendation follows the Food and Drug Administration’s (FDA) authorization for the vaccine for the age group last week. The protein-based vaccine received emergency use authorization in July for…

Novavax is seeking emergency authorization of its COVID-19 booster shot in adults aged 18 and older from U.S. regulators, the company announced on Monday. In a press release, the biotechnology company based in Maryland said it has submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) for its protein-based booster shot. If authorized, the…

Novavax Inc. on Monday halved its full-year revenue forecast as it does not expect further sales of its COVID-19 shot this year in the United States in the face of a global supply glut and soft demand, sending its shares down 33 percent. Novavax said it now expects 2022 total revenue in the range of…

The COVID-19 vaccine made by U.S.-based Novavax can lead to the same types of heart inflammation that have occurred after vaccination with the Pfizer and Moderna shots, Europe’s drug regulator said on Aug. 3. The European Medicines Agency said the vaccine, known as Nuvaxovid, should have myocarditis and pericarditis listed as side effects in the product…